Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The primary aim of this study is to evaluate the efficacy and non-inferiority of a lipid-lowering medication regimen comprised of the medications ezetimibe and fenofibrate taken daily, versus atorvastatin daily in lowering levels of low-density lipoprotein (LDL-C) cholesterol. Additionally, other aims would include effects on other types of blood cholesterol and examining the safety of the ezetimibe and fenofibrate regimen, as compared to atorvastatin.
Epistemonikos ID: 8786dcda4f788253e5ec0d25afca59c7ddb6286f
First added on: May 04, 2024